Process analysis of reduced specific productivity of TNFR-Fc in Chinese hamster ovary cells at high cell density

[1]  Natarajan Vijayasankaran,et al.  Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process , 2011, Biotechnology and bioengineering.

[2]  Li Fan,et al.  Effect of culture temperature on TNFR-Fc productivity in recombinant glutamine synthetase-chinese hamster ovary cells , 2010, Biotechnology Letters.

[3]  Wei-Shou Hu,et al.  Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment. , 2010, Journal of biotechnology.

[4]  Li Fan,et al.  Responses of GS-NS0 Myeloma cells to osmolality: Cell growth, intracellular mass metabolism, energy metabolism, and antibody production , 2009 .

[5]  M. Butler,et al.  Enhanced Production of Monomeric Interferon‐β by CHO Cells through the Control of Culture Conditions , 2008, Biotechnology progress.

[6]  S. Gupta,et al.  Effects of Elevated pCO2 and Osmolality on Growth of CHO Cells and Production of Antibody‐Fusion Protein B1: A Case Study , 2008, Biotechnology progress.

[7]  H. Katinger,et al.  Effect of Increased Expression of Protein Disulfide Isomerase and Heavy Chain Binding Protein on Antibody Secretion in a Recombinant CHO Cell Line , 2008, Biotechnology progress.

[8]  S. Sharfstein,et al.  Hyperosmotic Stress in Murine Hybridoma Cells: Effects on Antibody Transcription, Translation, Posttranslational Processing, and the Cell Cycle , 2008, Biotechnology progress.

[9]  Sung Hyun Kim,et al.  Effect of Low Culture Temperature on Specific Productivity and Transcription Level of Anti‐4–1BB Antibody in Recombinant Chinese Hamster Ovary Cells , 2008, Biotechnology progress.

[10]  Yuanxing Zhang,et al.  Gene transcription acceleration: main cause of hepatitis B surface antigen production improvement by dimethyl sulfoxide in the culture of Chinese hamster ovary cells , 2007, Biotechnology and bioengineering.

[11]  J. Piret,et al.  Decreased pCO2 accumulation by eliminating bicarbonate addition to high cell‐density cultures , 2007, Biotechnology and bioengineering.

[12]  Wei-Shou Hu,et al.  Fedbatch culture and dynamic nutrient feeding. , 2006, Advances in biochemical engineering/biotechnology.

[13]  W. Miller,et al.  Characterization of hybridoma cell responses to elevated pCO(2) and osmolality: intracellular pH, cell size, apoptosis, and metabolism. , 2002, Biotechnology and bioengineering.

[14]  G. Lee,et al.  Effect of hypoosmotic pressure on cell growth and antibody production in recombinant Chinese hamster ovary cell culture , 2001, Cytotechnology.

[15]  M. Fussenegger,et al.  A novel autoregulated proliferation-controlled production process using recombinant CHO cells. , 1999, Biotechnology and bioengineering.

[16]  W. Miller,et al.  Effects of CO2 and osmolality on hybridoma cells: growth, metabolism and monoclonal antibody production , 1998, Cytotechnology.

[17]  J. Ljunggren,et al.  Physiology of cultured animal cells. , 1997, Journal of biotechnology.

[18]  M. Shuler,et al.  Effect of elevated oxygen and glutamine levels on foreign protein production at high cell densities using the insect cell-baculovirus expression system. , 1997, Biotechnology and bioengineering.

[19]  A. Zeng.  Quantitative assessment of cell density effect on the metabolism and antibody production rate of hybridoma cells at high cell density , 1996 .

[20]  ROGER C. Thomas.  Bicarbonate briefly C02-free , 1995, Nature.

[21]  C A Smith,et al.  Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. , 1993, Journal of immunology.

[22]  J. Bailey,et al.  Effect of cloned gene dosage on cell growth and hepatitis B surface antigen synthesis and secretion in recombinant CHO cells , 1992, Biotechnology and bioengineering.

[23]  M. Flickinger,et al.  Use of a structured kinetic model of antibody synthesis and secretion for optimization of antibody production systems: I. Steady‐state analysis , 1992, Biotechnology and bioengineering.

[24]  M. Flickinger,et al.  A model of interorganelle monoclonal antibody transport and secretion in mouse hybridoma cells , 1991, Biotechnology and bioengineering.

[25]  M. Flickinger,et al.  A structured model for monoclonal antibody synthesis in exponentially growing and stationary phase hybridoma cells , 1991, Biotechnology and bioengineering.

[26]  E. Mandine,et al.  Evidence that monoclonal antibody production kinetics is related to the integral of the viable cells curve in batch systems , 1988, Biotechnology Letters.

[27]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[28]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .

[29]  G. Lee,et al.  Effect of Akt overexpression on programmed cell death in antibody-producing Chinese hamster ovary cells. , 2009, Journal of biotechnology.

[30]  M. Al‐Rubeai,et al.  Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells , 2009, Biotechnology and bioengineering.

[31]  Wei-Shou Hu,et al.  Alteration of mammalian cell metabolism by dynamic nutrient feeding , 2004, Cytotechnology.

[32]  Sigma S Mostafa,et al.  Strategies for Improved dCO2 Removal in Large‐Scale Fed‐Batch Cultures , 2003, Biotechnology progress.

[33]  G. Lee,et al.  Effects of Cloned Gene Dosage on the Response of Recombinant CHO Cells to Hyperosmotic Pressure in Regard to Cell Growth and Antibody Production , 2001, Biotechnology progress.

[34]  M. Fussenegger,et al.  Higher Productivity of Growth‐Arrested Chinese Hamster Ovary Cells Expressing the Cyclin‐Dependent Kinase Inhibitor p27 , 1998, Biotechnology progress.

[35]  J. Lehmann,et al.  Sialidase Activity in Culture Fluid of Chinese Hamster Ovary Cells during Batch Culture and Its Effect on Recombinant Human Antithrombin III Integrity , 1996, Biotechnology progress.

[36]  T. Bibila,et al.  In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production , 1995, Biotechnology progress.

[37]  Philip L. Altman,et al.  Respiration and Circulation , 1971 .